Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
The Dow Jones Industrial Average, a longtime bellwether for the U.S. economy, flirted this week with a high-water mark not seen since Lehman Brothers’ collapse triggered an economic implosion more than 4 years ago.
Rep. Erik Paulsen (R-Minn.) may have 228 co-sponsors for his bill to repeal the medical device tax, but he’s still missing some key members of the congressional caucus formed to support the medical device industry.
A newly uncovered Johnson & Johnson (NYSE:JNJ) email may pose problems for the health care giant in the ongoing lawsuits over defunct hip implants made by subsidiary DePuy Orthopaedics.
Billionaire hedge fund manager David Tepper, of Appaloosa Management, bought 7.8 million shares of Boston Scientific stock during the 4th quarter, according to regulatory filings, for a stake with a market value of $41.6 million as of Dec. 31.
The medical device industry will have its voice heard on Capitol Hill next week, as delegations for med-tech and other life science sectors from 18 states converge on the nation’s capitol to conduct coordinated visits to their local representatives in Congress.
Investors drove shares of Medtronic (NYSE:MDT) down on Wall Street after the company narrowed its fiscal 2012 earnings guidance. The declines came despite increased 3rd-quarter sales and earnings.
Johnson & Johnson (NYSE:JNJ) CEO William Weldon will step down in April and hand over the keys to the corner office to executive committee vice chairman Alex Gorsky.